Table A1.
Examples of quantitative lateral flow tests and their working ranges reached in combination with commercial detectors.
| Detector Model | Target Analytes | Range of Concentration Measured |
|---|---|---|
| Nemesys System (Bio-group Medical System) | Fecal occult blood | 30–1000 ng/mL |
| Calprotectin | 20–250 µg/g | |
| Tetanus | 0.01–0.51 IU/mL | |
| Celiac | 8–50 IU/mL | |
| CONCILE Ω100 (Concile) | Alpha-fetoprotein | 125–200 ng/mL |
| Cancer antigen 125 | 20–500 U/mL | |
| Carbohydrate antigen 15-3 | 10–400 U/mL | |
| Carbohydrate antigen 19-9 | 15–400 U/mL | |
| Carcinoembryonic antigen | 2.5–150 ng/mL | |
| Free prostate-specific antigen | 0.5–10 ng/mL | |
| Prostate-specific antigen | 0.5–25 ng/mL | |
| Urinary bladder cancer antigen | 5–300 µg/mL | |
| Human chorionic gonadotropin | 5–400 mIU/mL | |
| Luteinizing hormone | 5–200 mIU/mL | |
| Follicle-stimulating hormone | 2.5–100 mIU/mL | |
| Thyroid-stimulating hormone | 0.3–40 mIU/L | |
| Testosterone | 0.25–16 ng/mL | |
| 25-OH-vitamin D | 3–100 ng/mL | |
| C-reactive protein | 0.5–100 mg/L | |
| Neopterin | 2.5–100 nmol/L | |
| Brain natriuretic peptide | 100–3000 pg/mL | |
| Troponin I | 0.5–50 ng/mL | |
| Heart-type fatty-acid-binding protein | 2.5–100 ng/mL | |
| Phospholipase A2-IIA | 20–500 ng/mL | |
| Easy Reader (Vedalab) | Alpha-fetoprotein | 10–300 ng/mL |
| Beta-chain-specific human chorionic gonadotrophin | 5–1000 IU/L | |
| C-peptide | 0.5–40 ng/mL | |
| CA 125 (ovarian cancer antigen) | 15–750 U/mL | |
| Cancer antigen 15-3 | 5–200 IU/mL | |
| Calprotectin | 25–350 µg/g | |
| Carcinoembryonic antigen | 5–250 ng/mL | |
| Creatine kinase MB | 5–200 ng/mL | |
| Cortisol | 25–250 ng/mL | |
| C-reactive protein | 2.5–400 µg/mL | |
| High-sensitivity C-reactive protein | 0.1–400 µg/mL | |
| Cystatin C | 0.1–8 mg/L | |
| D-dimer | 250–5000 ng/mL | |
| Heart-type fatty-acid-binding protein | 2–120 ng/m | |
| Ferritin | 10–630 ng/mL | |
| Fecal occult blood (hemoglobin) | 10–499 ng/mL | |
| Follicle-stimulating hormone | 5–400 IU/L | |
| Hemoglobin total | 5–25 g/dL | |
| Glycated hemoglobin | 4%–16% | |
| Human chorionic gonadotrophin | 5–1000 IU/L | |
| High-sensitivity insulin | 2–200 µIU/mL | |
| High-sensitivity prolactin | 3–100 ng/mL | |
| High-sensitivity thyroid-stimulating hormone | 1–80 mIU/L | |
| Immunoglobulin E | 10–800 IU/mL | |
| Insulin | 5–200 µIU/mL | |
| Luteinizing hormone | 5–400 mIU/mL | |
| Microalbumin | 2.5–5000 µg/mL | |
| Myoglobin | 50–500 ng/mL | |
| Procalcitonin | 0.3–100 ng/mL | |
| Prolactin | 20–350 ng/mL | |
| Prostate-specific antigen | 1–100 ng/mL | |
| Total T3 | 0.3–6 ng/mL | |
| Total T4 | 0.6–15 µg/dL | |
| Transferrin | 4–300 ng/mL | |
| Troponin I | To 50 ng/mL | |
| Thyroid-stimulating hormone | 2–80 mIU/L | |
| Ultrasensitive thyroid-stimulating hormone | 0.2–50 mIU/L | |
| INCLIX (Sugentech) | Thyroid-stimulating hormone, vitamin D, D-dimer | No data published |
| Easy Reader (Megalab) | Alpha-fetoprotein, Cancer antigen 125, Carcinoembryonic antigen, Creatine kinase MB, C-reactive protein, high-sensitivity C-reactive protein, D-Dimer, Ferritin, Fecal occult blood, Follicle-stimulating hormone, Luteinizing hormone, IgE, Insulin, Luteinizing hormone, Microalbumin, Myoglobin, Prolactin, Prostate-specific antigen, Troponin I, Thyroid-stimulating hormone | No data published |